Cite
Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination
MLA
Stéphane Hugonnet, et al. “Prevention of Severe Candida Infections in Nonneutropenic, High-Risk, Critically Ill Patients: A Randomized, Double-Blind, Placebo-Controlled Trial in Patients Treated by Selective Digestive Decontamination.” Intensive Care Medicine, vol. 28, Dec. 2002, pp. 1708–17. EBSCOhost, https://doi.org/10.1007/s00134-002-1540-y.
APA
Stéphane Hugonnet, Jorge Garbino, Raymond Auckenthaler, Jacques-André Romand, Daniel Pablo Lew, & Didier Pittet. (2002). Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Medicine, 28, 1708–1717. https://doi.org/10.1007/s00134-002-1540-y
Chicago
Stéphane Hugonnet, Jorge Garbino, Raymond Auckenthaler, Jacques-André Romand, Daniel Pablo Lew, and Didier Pittet. 2002. “Prevention of Severe Candida Infections in Nonneutropenic, High-Risk, Critically Ill Patients: A Randomized, Double-Blind, Placebo-Controlled Trial in Patients Treated by Selective Digestive Decontamination.” Intensive Care Medicine 28 (December): 1708–17. doi:10.1007/s00134-002-1540-y.